Preliminary Schedule

• Fri, Feb 28
• Sat, Feb 29
• Sun, Mar 1

Friday, February 28, 2020

• 07:00 19:00

  Registration/ Inscription

  Room: Fortifications Foyer

• 07:00 08:00

  Breakfast/Petit Déjeuner

  Room: Fortifications

• 07:15 19:30

  9th Canadian Symposium on Hepatitis C Virus

  Advances in HCV Research and Treatment Towards Elimination

• 08:00 08:15

  Welcome and Introductions | Mot de Bienvenue

  Room: Montreal CD
  
  Curtis Cooper (Symposium Chair) | The Ottawa Hospital Research Institute
  Angela Crawley (Symposium Co-Chair) | The Ottawa Hospital Research Institute

• 08:15 09:15

  Biomedical Research ‑ HCV Vaccine Development and Related Studies

  Room: Montreal CD
  
  Seung-Hwan Lee (Co-Chair) | University of Ottawa 
  Che Colpitts (Co-Chair) | Queens University
  CanHepC trainees introducing Plenary Speakers  | Chisom Okwor and Vanessa Meier-Stephenson
  
  8:15 - 8:35 | Session - Vaccines for HCV - Where there is a Will there is a Way | Ellie Barnes | Oxford University, UK
  8:35 - 8:55 | Session - Progress towards a Global Prophylactic HCV Vaccine | John Law | University of Alberta, Canada
  8:55 - 9:15 | Questions/Panel Discussion 

• 09:15 09:45

  Oral Presentations

  Room: Montreal CD
  
  9:15 - 9:30 | Oral Abstract 1 | Differential gene expression of circulating CD8 T cells of cirrhotic HCV-infected individuals identifies pathways associated with lasting dysfunction | Angela M. Crawley | Ottawa Hospital Research Institute
  
  9:30 - 9:45 | Oral Abstract 2 | The Effect of Apoptosis and Inflammasome-Mediated Pyroptosis on HCV Infection | Hannah Louise Wallace | Memorial University

• 09:30 19:30

  Exhibition Hours

  Room: Fortifications

• 09:45 10:00

  Coffee Break | Pause Café and Poster Browsing

  Room: Fortifications

• 10:00 11:00

  Social, Cultural, Environmental, and Population Health Research – HCV in Underserved Populations: Modeling and Real‑Life Data to Inform Strategies

  Room: Montreal CD
  
  Julie Bruneau (Co-Chair) | Université de Montréal
  Nadine Kronfi (Co-Chair) | McGill University
  CanHepC trainees introducing Plenary Speakers  | Adam Palayew and Yasmin Saeed
  
  
  10:00 - 10:20 | Session: Tackling HCV transmission among people who inject drugs: insights from modeling - Natasha Martin | University of California San Diego, USA
  
  10:20 - 10:40 | Session: Hepatitis C Virus (HCV) Care in Canadian Correctional Facilities: The long road ahead towards HCV elimination - Nadine Kronfi | McGill University
  
  10:40 - 11:00 | Questions/Panel Discussion 

• 11:00 11:30

  Oral Presentations

  Room: Montreal CD
  
  11:00 - 11:15 | Oral Abstract 1 | Effect of Sustained Virologic Response and Opioid Agonist Therapy on Mortality Among People Living with Chronic Hepatitis C | Prince Adu | University of British Columbia
  
  11:15 - 11:30 | Oral Abstract 2 | Community and Corrections Based Point-of-Care Testing into a Provincial Hepatitis C Elimination Framework | Lisa Barrett | Dalhousie University

• 11:30 12:30

  Community Session ‑ “Connecting With Care”: Canadian Models of Hepatitis C Care‑ A Film Preview and Panel Discussion

  Room: Montreal CD

  Moderator: Melisa Dickie | Director, Hepatitis C Knowledge Exchange

  A Saskatchewan Story, Athakakoop Health Centre 
  Jodie Albert | Outreach Worker, Tanys Isbister, Community Health Nurse

  Montreal’s Many Models of Care 
  Martin Pagé | Executive Director, Dopamine
  Hugo Bissonne | Executive Director, Centre Sida Amitié
  Robert LaMarche | Outreach Worker, Centre Sida Amitié

  Toronto Community Hep C Program 
  Jennifer Broad | Community Health Worker
  Kate Mason | Researcher
  Jason Altenberg | CEO, South Riverdale Community Health Centre.

• 12:30 14:00

  Lunch and Poster Session | Présentation des Affiches

  Room: Fortifications
  
  13:00 - 13:45 | CanHepC evaluation of poster

• 14:00 14:55

  Clinical Research ‑ Hepatitis C Infection in Pregnancy & Children

  Room: Montreal CD
  
  Eve Roberts (Co-Chair) | Dalhousie University
  Hugo Soudeyns (Co-Chair) | Université de Montréal
  CanHepC trainees introducing Plenary Speakers:  Nanor Minoyan and Gillian Kolla
  
  14:00 - 14:20 | DAA use in Pregnancy - Robert Honegger | Nationwide Children's, USA
  14:20 - 14:40 | Pediatric Perspectives on DDA Use - Simon Ling | University of Toronto, Canada
  14:40 - 14:55 | Questions/Panel Discussion

• 14:55 15:25

  Oral Presentations

  Room: Montreal CD
  
  14:55 - 15:10 | Oral Abstract 1 | Efficacy of Sofosbuvir/Velpatasvir (S/V): Impact of Treatment Adherence | Brian Conway
  
  15:10 - 15:25 | Oral Abstract 2 | Reinfection Following Successful Direct-Acting Antiviral Therapy for Hepatitis C Infection Among People Who Inject Drugs | Evan Cunningham | The Kirby Institute, UNSW, Sydney, Australia

• 15:25 16:10

  Health Services Research – Blueprint Update and Implementation

  Room: Montreal CD

  Jason Altenberg (Co-Chair) | South Riverdale Community Health Centre
  Naveed Janjua (Co-Chair) | BCCDC

  15:25 - 15:35 | Blueprint Update | Jordan Feld | University of Toronto, Canada

  15:35 – 15:55 | Elimination Efforts in Nova Scotia and Prince Edward Island | Lisa Barrett | Dalhousie University, Halifax, Canada

  15:55 – 16:10 | Questions/Panel Discussion

• 16:10 16:40

  Oral Presentations

  Room: Montreal CD
  
  16:10 - 16:25 | Oral Abstract 1 | HBV-HCV Co Infection Among Immigrants in Ontario, Canada |Abdool S. Yasseen | University of Toronto, Canada
  
  16:25 - 16:40 | Oral Abstract 2 | The health burden of hepatitis C infection facing the First Nations population in Ontario: A Research Partnership | Andrew Mendlowitz | University of Toronto, Canada

• 16:40 16:50

  CanHepC Trainee Awards Ceremony

  Room: Montreal CD
  
  Christopher Richardson

• 16:50 16:55

  CanHepC Symposium Closing Remarks

  Room: Montreal CD
  
  Curtis Cooper | The Ottawa Hospital Research Institute
  Angela Crawley | The Ottawa Hospital Research Institute

• 16:55 17:05

  Canadian Liver Meeting Opening Remarks

  Room: Montreal CD
  
  Marc Bilodeau | Université de Montreal, Montreal, Canada

• 17:05 17:40

  CLM Opening Presentation ‑ Update on HCV Elimination in Canada and the US

  Room: Montreal CD
  
  Andrew Aronsohn | University of Chicago 

• 17:40 19:30

  Joint CanHepC and Canadian Liver Meeting Reception and CanHepC Poster Viewing

  Room: Fortifications
  Sabrina Mazouz | clm-p-168
  Rasika Kunden | clm-p-135
  Michael Palmer | clm-p-172

• 18:10 18:25

  Biomedical Poster Tour

  Room: Fortifications

  Chair: Rasika Kunden | CanHepC Trainee

  18:10 - 18:15: Sophie Cousineau | Poster No: CHC - P - 001 | Identifying the Role Played by the Poly(rC)-Binding Protein 2 (PCBP2) in the HCV Life Cycle

  18:15 - 18:20: Catia Perciani | Poster No: CHC - P - 004 | Precision-Cut Liver Slice (PCLS) Culture: A Model to Examine HCV Interactions with the Liver Microenvironment

  18:20 - 18:25 – Mohamed Abdelnabi | Poster No: CHC - P - 006 | Neutrophils are the major producers of the pro-fibrogenic cytokine IL-17A in non-alcoholic fatty liver disease (NAFLD)

• 18:10 18:25

  Social, Cultural, Environmental and Population Health Poster Tour

  Room: Fortifications

  Chair: Zoe Greenwald | CanHepC Trainee

  18:10 - 18:15: Adam Palayew | Poster No: CHC - P - 016 | Estimation of an Individual-Level Deprivation Index for HIV/HCV Coinfected Persons 

  18:15 - 18:20: Adelina Artenie | Poster No: CHC - P - 013 |  Diversity of Detention Patterns among People who Inject Drugs and the Associated Risk with Incident Hepatitis C Virus (HCV) Infection: Implications for Hepatitis C Prevention 

  18:20 - 18:25: Sofia Bartlett | Poster No: CHC - P - 012 |  Increasing Hepatitis C Screening & New Diagnoses in 10 British Columbia Provincial Correctional Centres from 2010-2019

• 18:35 19:00

  Clinical Poster Tour

  Room: Fortifications

  Chair: Jordan Feld | CanHepC Mentor

  18:35 - 18:40: Y. Mendoza | Poster No: CHC - P - 029 | Non-Invasive Surrogates of Portal Hypertension Predict Decompensation in Obese Patients with Compensated Ddvanced Chronic Liver Disease

  18:40 - 18:45: Valerie Martel-Laferriere | Poster No: CHC - P - 031 | Universal HCV and HIV Screening in an Emergency Room – Fewer New Cases than Expected

  18:45 - 18:50: Curtis Cooper | Poster No: CHC - P - 032 | DAA Treatment Uptake or Outcomes are Not Effected by Alcohol Use: A CANUHC Analysis

• 18:35 19:00

  Health Services Research Poster Tour

  Room: Fortifications

  Chair: Lisa Barrett | CanHepC Mentor

   18:35 - 18:40: William Wong | Poster No: CHC - P - 033 | Can we Afford to Screen and Treat Hepatitis C Virus (HCV) Infection in Canada? Latest Insight from a Canadian Policy Model – A Province-by-Province Analysis

  18:40 - 18:45: Gisela Macphail | Poster No: CHC - P - 038 | Hepatitis C (HCV) Re-Engagement Strategy after Loss to Follow-up

  18:45 - 18:50: Yasmin Saeed | Poster No: CHC - P - 036 |  Disparities in Health Utilities among Hepatitis C Patients Receiving Care in Different Settings